Home LiteratureArticle Details
PMID: 22935135 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Differential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particles.

Retrovirology ·Vol. 9 ·2012-08-30 ·Pages 71

Stirnnagel K, Schupp D, Dupont A, Kudryavtsev V, Reh J, Müllers E, Lamb DC, Lindemann D

Abstract

It is thought that foamy viruses (FVs) enter host cells via endocytosis because all FV glycoproteins examined display pH-dependent fusion activities. Only the prototype FV (PFV) glycoprotein has also significant fusion activity at neutral pH, suggesting that its uptake mechanism may deviate from other FVs. To gain new insights into the uptake processes of FV in individual live host cells, we developed fluorescently labeled infectious FVs. N-terminal tagging of the FV envelope leader peptide domain with a fluorescent protein resulted in efficient incorporation of the fluorescently labeled glycoprotein into secreted virions without interfering with their infectivity. Double-tagged viruses consisting of an eGFP-tagged PFV capsid (Gag-eGFP) and mCherry-tagged Env (Ch-Env) from either PFV or macaque simian FV (SFVmac) were observed during early stages of the infection pathway. PFV Env, but not SFVmac Env, containing particles induced strong syncytia formation on target cells. Both virus types showed trafficking of double-tagged virions towards the cell center. Upon fusion and subsequent capsid release into the cytosol, accumulation of naked capsid proteins was observed within four hours in the perinuclear region, presumably representing the centrosomes. Interestingly, virions harboring fusion-defective glycoproteins still promoted virus attachment and uptake, but failed to show syncytia formation and perinuclear capsid accumulation. Non-fused or non-fusogenic viruses are rapidly cleared from the cells by putative lysosomal degradation. Monitoring the fraction of viruses containing both Env and capsid signals as a function of time demonstrated that PFV virions fused within the first few minutes, whereas fusion of SFVmac virions was less pronounced and observed over the entire 90 minutes measured. The characterized double-labeled FVs described here provide new mechanistic insights into FV early entry steps, demonstrating that productive viral fusion occurs early after target cell attachment and uptake. The analysis highlights apparent differences in the uptake pathways of individual FV species. Furthermore, the infectious double-labeled FVs promise to provide important tools for future detailed analyses on individual FV fusion events in real time using advanced imaging techniques.

MeSH Terms
Capsid Proteins/genetics,metabolism Cell Line Fluorescence Humans Hydrogen-Ion Concentration Luminescent Proteins/genetics,metabolism Recombinant Fusion Proteins/genetics,metabolism Spumavirus/drug effects,physiology Staining and Labeling/methods Viral Envelope Proteins/genetics,metabolism Virology/methods Virus Internalization/drug effects
Chemicals
Capsid Proteins Luminescent Proteins Recombinant Fusion Proteins Viral Envelope Proteins
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Stirnnagel Kristin
Institute of Virology, Medizinische Fakultät "Carl Gustav Carus", Technische Universität Dresden, Fetscherstr, 74, 01307 Dresden, Germany.
Schupp Dorothee
Dupont Aurélie
Kudryavtsev Volodymyr
Reh Juliane
Müllers Erik
Lamb Don C
Lindemann Dirk
References (56)
56 references, click to expand
  1. Virus entry by endocytosis.
    Annu Rev Biochem. 2010;79:803-33 PMID: 20196649
  2. Protease-dependent uncoating of a complex retrovirus.
    J Virol. 2005 Jul;79(14):9244-53 PMID: 15994819
  3. Alternating-laser excitation of single molecules.
    Acc Chem Res. 2005 Jul;38(7):523-33 PMID: 16028886
  4. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity.
    J Virol. 2001 Jul;75(13):5762-71 PMID: 11390578
  5. A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.
    Mol Ther. 2012 Jun;20(6):1167-76 PMID: 22472951
  6. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    J Virol. 2004 Oct;78(19):10803-13 PMID: 15367647
  7. Visualization of the intracellular behavior of HIV in living cells.
    J Cell Biol. 2002 Nov 11;159(3):441-52 PMID: 12417576
  8. A monomeric red fluorescent protein.
    Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7877-82 PMID: 12060735
  9. Conversion of the monomeric red fluorescent protein into a photoactivatable probe.
    Chem Biol. 2005 Mar;12(3):279-85 PMID: 15797211
  10. Prototype foamy virus gag nuclear localization: a novel pathway among retroviruses.
    J Virol. 2011 Sep;85(18):9276-85 PMID: 21715475
  11. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.
    J Virol. 1997 Jun;71(6):4815-20 PMID: 9151877
  12. Dynasore, a cell-permeable inhibitor of dynamin.
    Dev Cell. 2006 Jun;10(6):839-50 PMID: 16740485
  13. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.
    J Virol. 1995 Jun;69(6):3407-19 PMID: 7745687
  14. Visualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy.
    Retrovirology. 2009 Sep 18;6:84 PMID: 19765276
  15. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8.
    J Cell Sci. 2003 Aug 15;116(Pt 16):3433-42 PMID: 12857789
  16. Foamy virus particle formation.
    J Virol. 1998 Feb;72(2):1610-5 PMID: 9445065
  17. The foamy virus envelope glycoproteins.
    Curr Top Microbiol Immunol. 2003;277:111-29 PMID: 12908770
  18. Inhibition of endosome-lysosome system acidification enhances porcine circovirus 2 infection of porcine epithelial cells.
    J Virol. 2008 Feb;82(3):1128-35 PMID: 18032516
  19. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step.
    J Virol. 1997 Feb;71(2):1155-61 PMID: 8995637
  20. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.
    Mol Cell Biol. 1987 Jan;7(1):379-87 PMID: 3031469
  21. Improved primate foamy virus vectors and packaging constructs.
    J Virol. 2002 Apr;76(8):3774-83 PMID: 11907217
  22. Viral stop-and-go along microtubules: taking a ride with dynein and kinesins.
    Trends Microbiol. 2005 Jul;13(7):320-7 PMID: 15950476
  23. Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis.
    J Virol. 2011 Feb;85(4):1452-63 PMID: 21106749
  24. Retrotransposition and cell-to-cell transfer of foamy viruses.
    J Virol. 2003 Nov;77(21):11855-8 PMID: 14557671
  25. Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection.
    J Virol. 1998 Dec;72(12):9645-55 PMID: 9811698
  26. Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release.
    J Virol. 2005 Dec;79(24):15074-83 PMID: 16306578
  27. Foamy viruses are unconventional retroviruses.
    J Virol. 1999 Mar;73(3):1747-55 PMID: 9971751
  28. Subviral particle release determinants of prototype foamy virus.
    J Virol. 2008 Oct;82(20):9858-69 PMID: 18684814
  29. Single-particle tracking as a quantitative microscopy-based approach to unravel cell entry mechanisms of viruses and pharmaceutical nanoparticles.
    Mol Ther. 2011 Jul;19(7):1199-211 PMID: 21654634
  30. Electron microscopic observations on the mechanisms of entry of simian foamy virus in HEp-2 cells.
    J Gen Virol. 1973 Apr;19(1):135-9 PMID: 4360628
  31. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity.
    J Virol. 2000 May;74(10):4474-82 PMID: 10775583
  32. Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells.
    Mol Ther. 2012 Jun;20(6):1158-66 PMID: 22434139
  33. Chromatin tethering of incoming foamy virus by the structural Gag protein.
    Traffic. 2008 Sep;9(10):1717-27 PMID: 18627573
  34. How viruses enter animal cells.
    Science. 2004 Apr 9;304(5668):237-42 PMID: 15073366
  35. Endocytosis unplugged: multiple ways to enter the cell.
    Cell Res. 2010 Mar;20(3):256-75 PMID: 20125123
  36. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies.
    Traffic. 2003 Nov;4(11):785-801 PMID: 14617360
  37. Genistein, a specific inhibitor of tyrosine-specific protein kinases.
    J Biol Chem. 1987 Apr 25;262(12):5592-5 PMID: 3106339
  38. Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells.
    J Cell Biol. 2005 Jul 18;170(2):317-25 PMID: 16027225
  39. Heparan sulfate is an attachment factor for foamy virus entry.
    J Virol. 2012 Sep;86(18):10028-35 PMID: 22787203
  40. Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing.
    J Virol. 1998 May;72(5):4088-94 PMID: 9557698
  41. Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles.
    Retrovirology. 2010 May 17;7:45 PMID: 20478027
  42. The structure of the chromophore within DsRed, a red fluorescent protein from coral.
    Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11990-5 PMID: 11050230
  43. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity.
    J Virol. 2004 Dec;78(24):13865-70 PMID: 15564494
  44. Four-dimensional imaging and quantitative reconstruction to analyse complex spatiotemporal processes in live cells.
    Nat Cell Biol. 2001 Sep;3(9):852-5 PMID: 11533667
  45. Mechanisms of viral entry: sneaking in the front door.
    Protoplasma. 2010 Aug;244(1-4):15-24 PMID: 20446005
  46. Centrosomal latency of incoming foamy viruses in resting cells.
    PLoS Pathog. 2007 May 25;3(5):e74 PMID: 17530924
  47. Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways.
    Blood. 2011 Jun 9;117(23):6392-403 PMID: 21482707
  48. Double-labelled HIV-1 particles for study of virus-cell interaction.
    Virology. 2007 Mar 30;360(1):92-104 PMID: 17097708
  49. Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell.
    Virology. 2007 Apr 10;360(2):286-93 PMID: 17123568
  50. Dark states in monomeric red fluorescent proteins studied by fluorescence correlation and single molecule spectroscopy.
    Biophys J. 2008 May 15;94(10):4103-13 PMID: 18234806
  51. Characterization of a newly derived human sarcoma cell line (HT-1080).
    Cancer. 1974 Apr;33(4):1027-33 PMID: 4132053
  52. Subversion of the actin cytoskeleton during viral infection.
    Nat Rev Microbiol. 2011 Jun;9(6):427-39 PMID: 21522191
  53. Virus trafficking - learning from single-virus tracking.
    Nat Rev Microbiol. 2007 Mar;5(3):197-208 PMID: 17304249
  54. The cell biology of receptor-mediated virus entry.
    J Cell Biol. 2011 Dec 26;195(7):1071-82 PMID: 22123832
  55. Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process.
    J Virol. 2003 Apr;77(8):4722-30 PMID: 12663779
  56. Transplasma membrane electron and proton transport is inhibited by chloroquine.
    Biochem Int. 1990;21(4):761-9 PMID: 2173587
Article Info
Journal
Retrovirology
Abbr.
Retrovirology
ISSN
1742-4690
Published
2012-08-30
Epub
2012-00-30
Pages
71
Language
English
Region
England
NLM ID
101216893
PMCID
PMC3495412
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com